|0.6299||-0.0302 / -4.58%|
As of 4:00pm ET
|0.6299||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a +535.02% increase from the last price of 0.63.
The current consensus among 7 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.